Agilent Posts Falloff in Q1 Revenues and Profit, Plans More Layoffs

Revenues for the firm's Bio-Analytical Measurement segment fell 1 percent year over year — a relative bright spot for the firm, which saw revenues for its Semiconductor and Board Test and Electronic Measurement segments plummet 49 percent and 23 percent, respectively.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories